Pfizer

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,715.05
-107.8 (-2.24%)
BSENSE

Mar 19

BSE+NSE Vol: 7.95 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 11.90% vs 2.61% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 19.68% vs 17.23% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 30.31% vs 15.00% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 28.85% vs -32.39% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Pfizer With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,890.42
0
1,890.42
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,890.42
0
1,890.42
Raw Material Cost
226.47
0
226.47
Purchase of Finished goods
490.70
0
490.70
(Increase) / Decrease In Stocks
-53.22
0
-53.22
Employee Cost
290.79
0
290.79
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
267.54
0.00
267.54
Total Expenditure (Excl Depreciation)
1,222.28
0
1,222.28
Operating Profit (PBDIT) excl Other Income
668.14
0.00
668.14
Other Income
147.23
0
147.23
Operating Profit (PBDIT)
815.37
0
815.37
Interest
7.37
0
7.37
Exceptional Items
-58.20
0
-58.20
Gross Profit (PBDT)
749.80
0
749.80
Depreciation
42.95
0
42.95
Profit Before Tax
706.85
0
706.85
Tax
184.24
0
184.24
Provisions and contingencies
0.00
0
0.00
Profit After Tax
522.61
0
522.61
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
522.61
0
522.61
Equity Capital
45.75
0
45.75
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.00
0
0.00
Operating Profit Margin (Excl OI)
35.34%
0%
0.00
35.34%
Gross Profit Margin
39.66%
0%
0.00
39.66%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,890.42 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 11.90% vs 2.61% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 522.61 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 19.68% vs 17.23% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 668.14 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 30.31% vs 15.00% in Dec 2024

Nine Monthly - Interest
Interest 7.37 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 28.85% vs -32.39% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.34%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024